{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P28908",
      "entity_text" : "CD30",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_Y548" ],
      "TissueType" : [ "tissuelist:TS-1001" ],
      "Organ" : [ "uberon:UBERON:0000105" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "It has been reported that CD30 expression is a favorable prognostic factor in a cohort of 903 patients with de novo DLBCL.22 Patients with CD30 + DLBCL had a superior 5-year OS (CD30 +, 79% vs CD30 -, 50%; P =.001 and PFS (P =.003).22 The favorable outcome of CD30 + expression was maintained in both the germinal center and activated B-cell subtypes.22 4 CONCLUSION.",
  "reading_complete" : "2020-08-03T15:30:05Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:29:29Z",
  "trigger" : "expression",
  "evidence" : [ "CD30 expression" ],
  "pmc_id" : "7044370",
  "score" : 0
}